Manfred Schmitt
Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau · 835 works · 38,577 citations · h-index 96
Top works
- Differences Between Tight and Loose Cultures: A 33-Nation Study
- A Meta-Analysis on the Correlation Between the Implicit Association Test and Explicit Self-Report Measures
- Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1
- Recommendations for Increasing Replicability in Psychology
- Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer
- Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
- Increased Neutrophil-Platelet Adhesion in Patients With Unstable Angina
- Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients
- Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
- Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy
- The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancer
- Clinical Relevance of the Urokinase-Type and Tissue-Type Plasminogen Activators and of Their Type 1 Inhibitor in Breast Cancer
- Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood–brain barrier
- Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.
- Latent state-trait theory and research in personality and individual differences
- Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b
- Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
- States and traits in psychological assessment.
- Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.